IN
Amplia Therapeutics Limited
INNMF · OTC
$0.08 +6.31% (+$0.00)
1M -20.52%
Market Cap $60.2M
P/E Ratio -
Div. Yield -
ROE 22.61%
Piotroski F-Score Weak
1/9Valuation
35 /100
Fair P/B 2.86x
P/S 15.90x
P/FFO N/A
Growth
82 /100
Growing Book val. growth 1.27%
Rev. growth 24.02%
FCF growth N/A
Profitability
20 /100
Weak Op. margin 172.22%
Gross margin 94.43%
FCF margin 182.04%
Quality
2 /100
Poor ROA 28.65%
ROIC 30.94%
Asset turnover 0.16x
Debt
100 /100
Low Current ratio 7.91x
Debt/Equity 0.00x
Debt/Assets N/A
Stability
34 /100
Moderate EPS volatility 28.77%
Beta -0.40x
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na INNMF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Christopher J. Burns
Employees
1
Headquarters
Melbourne
Nadcházející události
27 LIS
Earnings
Upcoming earnings report